May Peter, Garrido Melissa M, Aldridge Melissa D, Cassel J Brian, Kelley Amy S, Meier Diane E, Normand Charles, Penrod Joan D, Smith Thomas J, Morrison R Sean
Centre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland; Icahn School of Medicine at Mount Sinai, New York, New York.
Icahn School of Medicine at Mount Sinai, New York, New York; James J. Peters VA Medical Center, New York, New York.
J Hosp Med. 2017 Jun;12(6):407-413. doi: 10.12788/jhm.2745.
Inpatient hospital stays account for more than a third of direct medical cancer care costs. Evidence on factors driving these costs can inform planning of services, as well as consideration of equity in access.
To measure the association between hospital costs, and demographic, clinical, and system factors, for a cohort of adults with advanced cancer.
Prospective multisite cohort study.
Four medical and cancer centers.
Adults with advanced cancer admitted to a participating hospital between 2007 and 2011, excluding those with dementia. Final analytic sample included 1020 patients.
With receipt of palliative care controlled for, the associations between hospital cost and patient factors were estimated. Factors covered the domains of demographics (age, sex, race), socioeconomics and systems (education, insurance, living will, proxy), clinical care (diagnoses, complications deemed to pose a threat to life or bodily functions, comorbidities, symptom burden, activities of daily living), and prior healthcare utilization (home help, analgesic prescribing).
Direct hospital costs.
A major (markedly abnormal) complication (+$8267; P < 0.01), a minor but not a major complication (+$5289; P < 0.01), and number of comorbidities (+$852; P < 0.01) were associated with higher cost, and admitting diagnosis of electrolyte disorders (-$4759; P = 0.01) and increased age (-$53; P = 0.03) were associated with lower cost.
Complications and comorbidity burden drive inhospital utilization for adults with advanced cancer. There is little evidence of sociodemographic associations and no apparent impact of advance directives. Attempts to control growth of hospital cancer costs require consideration of how the most resource-intensive patients are identified promptly and prioritized for cost-effective care. Journal of Hospital Medicine 2017;12:407-413.
住院治疗费用占癌症直接医疗护理费用的三分之一以上。了解影响这些费用的因素有助于服务规划以及对医疗公平性的考量。
测量晚期癌症成年患者队列的住院费用与人口统计学、临床及系统因素之间的关联。
前瞻性多中心队列研究。
四家医疗和癌症中心。
2007年至2011年间入住参与研究医院的晚期癌症成年患者,不包括患有痴呆症的患者。最终分析样本包括1020名患者。
在控制姑息治疗的情况下,估计住院费用与患者因素之间的关联。因素涵盖人口统计学(年龄、性别、种族)、社会经济学和系统(教育程度、保险、生前预嘱、代理人)、临床护理(诊断、被认为对生命或身体功能构成威胁的并发症、合并症、症状负担、日常生活活动能力)以及先前的医疗保健利用情况(家庭帮助、镇痛药处方)。
直接住院费用。
严重(明显异常)并发症(增加8267美元;P<0.01)、轻微但非严重并发症(增加5289美元;P<0.01)以及合并症数量(增加852美元;P<0.01)与费用增加相关,而电解质紊乱的入院诊断(减少4759美元;P = 0.01)和年龄增加(减少53美元;P = 0.03)与费用降低相关。
并发症和合并症负担推动晚期癌症成年患者的住院治疗利用。几乎没有社会人口统计学关联的证据,生前预嘱也无明显影响。控制医院癌症费用增长的尝试需要考虑如何及时识别资源消耗最大的患者并将其列为成本效益护理的优先对象。《医院医学杂志》2017年;12:407 - 413。